Company / Working Capital
Baxter International Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.9B
FY2025
5-year range
$2.3B / $4.6B
FY2021-FY2025
Trend
+66.6%
vs FY2024
Sector context
#11 of 160
Health Care
What the data says
Among 160 Health Care companies, Baxter International is in the top 7% for working capital. Working Capital returned to growth in FY2025 after 4 years of decline, reaching $3.9B.
Based on SEC 10-K filings.
$3.9B in FY2025 with a 5-year CAGR of -5.1%. Top quartile in the Health Care sector.
Improved from $3.1B to $3.9B over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- -5.1%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 160This company $3.9B Sector average $757.1M
▼
+415.4% above sector average
Key checks
Key Insights
- 5-year CAGR of -5.1%, indicating a declining trend.
- In FY2025, working capital increased 66.6% year-over-year.
- Ranks #11 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2020.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9B | +66.6% |
| FY2024 | $2.3B | -24.4% |
| FY2023 | $3.1B | -5.2% |
| FY2022 | $3.3B | -29.6% |
| FY2021 | $4.6B | -8.7% |
| FY2020 | $5.1B | +18.8% |
| FY2019 | $4.3B | -1.9% |
| FY2018 | $4.4B | -2.0% |
| FY2017 | $4.4B | +16.0% |
| FY2016 | $3.8B | -36.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026